
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. (PVLA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PVLA · as of Jun 9, 2026
Activity summary
Buy transactions
5
P-Purchase only
Sell transactions
18
12 Months
Buy/Sell ratio
0.28
Buy/Sell (by trades)
Overall sentiment
Palvella Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
PVLA insider buying and selling by quarter
PVLA insider selling · PVLA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · PVLA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
PVLA executive sell shares · PVLA board member insider trading · PVLA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 20, 2026 | Goin Kathleen COO | Option | 2,148 | $20K | Form 4 |
| May 20, 2026 | Goin Kathleen COO | Option | 2,154 | $15K | Form 4 |
| May 20, 2026 | Goin Kathleen COO | Sale | 3,363 | $371K | Form 4 |
| May 20, 2026 | Goin Kathleen COO | Sale | 891 | $99K | Form 4 |
| May 20, 2026 | Goin Kathleen COO | Sale | 48 | $5K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Option | 2,148 | $20K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Sale | 1,502 | $189K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Option | 2,154 | $15K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Sale | 1,500 | $191K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Sale | 561 | $72K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Sale | 639 | $83K | Form 4 |
| Apr 15, 2026 | Goin Kathleen COO | Sale | 100 | $13K | Form 4 |
| Mar 30, 2026 | JENKINS GEORGE M Director | Purchase | 445 | $50K | Form 4 |
| Mar 18, 2026 | Goin Kathleen COO | Option | 2,148 | $20K | Form 4 |
| Mar 18, 2026 | Goin Kathleen COO | Option | 2,154 | $15K | Form 4 |
| Mar 18, 2026 | Goin Kathleen COO | Sale | 2,268 | $267K | Form 4 |
| Mar 18, 2026 | Goin Kathleen COO | Sale | 1,730 | $205K | Form 4 |
| Mar 18, 2026 | Goin Kathleen COO | Sale | 304 | $36K | Form 4 |
| Feb 27, 2026 | JENKINS GEORGE M Director | Purchase | 4,000 | $500K | Form 4 |
| Feb 27, 2026 | HERON ELAINE J Director | Purchase | 2,400 | $300K | Form 4 |
| Feb 18, 2026 | Goin Kathleen COO | Option | 2,148 | $20K | Form 4 |
| Feb 18, 2026 | Goin Kathleen COO | Option | 2,154 | $15K | Form 4 |
| Feb 18, 2026 | Goin Kathleen COO | Sale | 3,026 | $240K | Form 4 |
| Feb 18, 2026 | Goin Kathleen COO | Sale | 1,276 | $102K | Form 4 |
| Jan 21, 2026 | Goin Kathleen COO | Option | 2,148 | $20K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PVLA insider trading
PVLA insider trades
Palvella Therapeutics, Inc. (PVLA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Goin Kathleen (COO), JENKINS GEORGE M (Director), HERON ELAINE J (Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. PVLA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Palvella Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PVLA insider trading · 5 questionsThe insiders of Palvella Therapeutics, Inc. (PVLA) include executives and directors such as Goin Kathleen (COO), JENKINS GEORGE M (Director), HERON ELAINE J (Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026